Genomics Meets Real-World Data
Beyond ICD Codes: Unlocking Rare Disease Insights With Genomics and Claims-Based Data

ICD-10 codes miss rare disease patients and mislabel others. Disease mimics slip into cohorts, and the gap between diagnosis and treatment stays hidden.

Lisa Gurry, Chief Business Officer, and Colleen Caleshu, Senior Director of Translational Research, share how GeneDx clinically interpreted genomic data confirms who has a rare disease. Rathi Suresh, VP of Analytics at Komodo Health, shows how linking that data with longitudinal claims, across a 92% patient token overlap, reveals how those patients are treated and where care falls short. Science writer Jaime Green moderates.

In This On Demand Webinar, You’ll:

• See how genetic data removes phenocopies from HCM cohorts, and why genetically characterized patients were 1.7x more likely to receive a defibrillator
• Learn how linked data sharpens trial site selection and patient finding beyond ICD code searches
• Find the gap between genetic confirmation and FDA-approved therapy in CDKL5 deficiency disorder
• Hear why the speakers see genetic evidence as a drug development advantage, citing costs up to 25% lower and 2.6x higher odds of success
• Understand how Marmot™, Komodo’s AI-powered analytics platform, produces transparent, reproducible insights that hold up to regulatory and scientific review